Boston Scientific acquires Endotex, the latest exit for serial entrepreneur Khosravi
Boston Scientic has acquired Cupertino stent maker, Endotex, for an undisclosed amount.
Endotex had raised more than $25 million in venture funding, including from Delphi Ventures, Guidant Corp., New Enterprise Associates, New Venture Partners, Onset Ventures, US Surgical and Saratoga Ventures. Boston Scientific had also owned a stake.
It is the latest accomplishment for Endotex founder Fred Khosravi, who had previously built another company, EPI, also bought by Boston Scientific. He’s founded seven medical device companies. He’s now working on another, Access Closure.
Next Story: Plusmo slides content across your idle mobile phone
Previous Story: Kolorific, fabless semiconductor for flat-panel HDTVs, raises $7M
